Alan C Moss1. Show Affiliations » 1. Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, Massachusetts.
Abstract
Entities: Disease
Mesh： See more » AdalimumabAnti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal, Humanized/bloodAntibodies, Monoclonal, Humanized/therapeutic useCertolizumab PegolCrohn Disease/drug therapyCrohn Disease/pathologyFemaleHumansImmunoglobulin Fab Fragments/bloodImmunoglobulin Fab Fragments/therapeutic useImmunosuppressive Agents/bloodImmunosuppressive Agents/therapeutic useMalePolyethylene Glycols/therapeutic use
Substances： See more » Anti-Inflammatory AgentsAntibodies, Monoclonal, HumanizedImmunoglobulin Fab FragmentsImmunosuppressive AgentsPolyethylene GlycolsAdalimumabCertolizumab Pegol
Year: 2013 PMID： 24370555 DOI： 10.1016/j.cgh.2013.12.022
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN： 1542-3565 Impact factor: 11.382